Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker
暂无分享,去创建一个
Francesco Giganti | Antonio Esposito | Alessandro Ambrosi | Sofia Antunes | Elena Orsenigo | F. Giganti | A. Del Maschio | L. Albarello | A. Ambrosi | A. Esposito | R. Nicoletti | F. de Cobelli | E. Orsenigo | C. Staudacher | Luca Albarello | Alessandro Del Maschio | Paolo Marra | Annalaura Salerno | Damiano Chiari | Roberto Nicoletti | Carlo Staudacher | Francesco De Cobelli | P. Marra | A. Salerno | D. Chiari | S. Antunes
[1] A. Jemal,et al. Global Cancer Statistics , 2011 .
[2] Matthew J. McAuliffe,et al. Medical Image Processing, Analysis and Visualization in clinical research , 2001, Proceedings 14th IEEE Symposium on Computer-Based Medical Systems. CBMS 2001.
[3] Bal Sanghera,et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.
[4] S. Nonogaki,et al. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] H. Honda,et al. Extent of arterial tumor enhancement measured with preoperative MDCT gastrography is a prognostic factor in advanced gastric cancer after curative resection. , 2013, AJR. American journal of roentgenology.
[6] H. Lee,et al. Mucinous gastric carcinomas , 2009, Cancer.
[7] C. V. D. van de Velde,et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.
[8] Balaji Ganeshan,et al. Quantifying tumour heterogeneity with CT , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.
[9] C. Mariette,et al. Predicting the response to chemotherapy in gastric adenocarcinoma: who benefits from neoadjuvant chemotherapy? , 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[10] T. Kwee,et al. Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer. , 2014, World journal of gastroenterology.
[11] Dina Muin,et al. Texture-based classification of different gastric tumors at contrast-enhanced CT. , 2013, European journal of radiology.
[12] David R. Anderson,et al. Information and Likelihood Theory: A Basis for Model Selection and Inference , 2004 .
[13] V. Goh,et al. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.
[14] S. Mocellin,et al. The Ratio Between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Regardless of the Type of Lymphadenectomy: Results From an Italian Multicentric Study in 1853 Patients , 2007, Annals of surgery.
[15] Udaya B. Kogalur,et al. High-Dimensional Variable Selection for Survival Data , 2010 .
[16] Diana Anderson,et al. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. , 2004, Genes & development.
[17] V. Goh,et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. , 2013, Radiology.
[18] R. Hill,et al. The tumor microenvironment and metastatic disease , 2008, Clinical & Experimental Metastasis.
[19] S. Venkatesh,et al. CT volumetry for gastric carcinoma: association with TNM stage , 2014, European Radiology.
[20] K. Miles,et al. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.
[21] Philippe Lambin,et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. , 2007, International journal of radiation oncology, biology, physics.
[22] F. Stingo,et al. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. , 2014, Blood.
[23] Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.
[24] A. Axon,et al. Gastric cancer: a curable disease in Britain. , 1993, BMJ.
[25] F. Giganti,et al. Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography , 2015, Gastric Cancer.
[26] Y. Doki,et al. Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer , 2015, European Radiology.
[27] V. Goh,et al. Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. , 2013, Radiology.
[28] H. Ishwaran,et al. A novel approach to cancer staging: application to esophageal cancer. , 2009, Biostatistics.
[29] Y. Itai,et al. Gastric tumors: radiologic-pathologic correlation and accuracy of T staging with dynamic CT. , 1992, Radiology.
[30] S. Roman,et al. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] R. Langer,et al. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] P. Hohenberger,et al. Gastric cancer. , 2003, Lancet.
[33] John O'Quigley,et al. An application of changepoint methods in studying the effect of age on survival in breast cancer , 1999 .
[34] S. Kitano,et al. Pathology and prognosis of gastric carcinoma , 2000, Cancer.
[35] David R. Anderson,et al. Model selection and multimodel inference : a practical information-theoretic approach , 2003 .
[36] V. Goh,et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.
[37] A. Ba-Ssalamah,et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer , 2016, European Radiology.
[38] G. Liu,et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT--correlation with surgical and histopathologic results. , 2007, Radiology.
[39] G. Semenza,et al. HIF-1 and tumor progression: pathophysiology and therapeutics. , 2002, Trends in molecular medicine.
[40] H. Honda,et al. Differentiation of early gastric cancer with ulceration and resectable advanced gastric cancer using multiphasic dynamic multidetector CT , 2016, European Radiology.
[41] Luigi Gianolli,et al. Response to chemotherapy in gastric adenocarcinoma with diffusion‐weighted MRI and 18F‐FDG‐PET/CT: Correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade , 2014, Journal of magnetic resonance imaging : JMRI.
[42] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[43] A. Davey,et al. Prognostic significance of signet ring gastric cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.